Skip to Main Content
An official website of the United States government

Prostate Cancer Clinical Outcomes

Principal Investigator

Name
K.C Balaji

Degrees
M.D

Institution
UF Health Jacksonville

Position Title
Professor and Chair

Email
kethandapatti.balaji@jax.ufl.edu

About this CDAS Project

Study
PLCO (Learn more about this study)

Project ID
PLCO-1139

Initial CDAS Request Approval
Jan 3, 2023

Title
Prostate Cancer Clinical Outcomes

Summary
We are trying to evaluate variables that are associated with incidence and mortality of prostate cancer and correlating them with genetic mutations. We are also assessing low risk vs high risk prostate cancer patients and correlating them with next generation sequencing results and potentially identifying specific biochemical and radiological markers to help with screening and management. With this large sample dataset we are able to validate our clinical and genomic findings and understand the role that mutations have in initiation of tumorigenesis and disease progression.

Aims

- Evaluating clinical outcomes in prostate cancer.
- Correlating genetic mutations with biochemical and radiological markers.
- Role of next generation sequencing in prostate cancer.
- Understanding genetic pathways that relate to disease progression.

Collaborators

Mohammed Al-Toubat University of Florida Health, Jacksonville